메뉴 건너뛰기




Volumn 43, Issue 3, 2011, Pages 306-310

Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise

Author keywords

Adverse effect; early fetal demise; misoprostol; oral route; sublingual route

Indexed keywords

MISOPROSTOL;

EID: 79958271270     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.81513     Document Type: Article
Times cited : (8)

References (17)
  • 3
    • 0028926771 scopus 로고
    • Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol
    • El-Refacy H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Eng J Med 1995;332:983-7.
    • (1995) N Eng J Med , vol.332 , pp. 983-987
    • El-Refacy, H.1    Rajasekar, D.2    Abdalla, M.3    Calder, L.4    Templeton, A.5
  • 4
    • 0030801779 scopus 로고    scopus 로고
    • Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy
    • DOI 10.1016/S0029-7844(97)00419-5, PII S0029784497004195
    • Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW. Vaginal misopristol compared with oral misopristol in termination of second trimester pregnancy. Obstet Gynecol 1997;90:735-8. (Pubitemid 27449724)
    • (1997) Obstetrics and Gynecology , vol.90 , Issue.5 , pp. 735-738
    • Ho, P.-C.1    Ngai, S.-W.2    Liu, K.-L.3    Wong, G.C.-Y.4    Lee, S.W.-H.5
  • 5
    • 0030933135 scopus 로고    scopus 로고
    • The use of misoprostol for termination of early pregnancy
    • DOI 10.1016/S0010-7824(97)00020-6, PII S0010782497000206
    • Carbonell JL, Varela L, Velazeo A, Fernandez C. The use of misopristol for termination of early pregnancy. Contraception 1997;55:165-8. (Pubitemid 27180392)
    • (1997) Contraception , vol.55 , Issue.3 , pp. 165-168
    • Carbonell, J.L.L.1    Varela, L.2    Velazco, A.3    Fernandez, C.4
  • 7
    • 0036182991 scopus 로고    scopus 로고
    • Pharmacokinetics of different routes of administration of misoprostol
    • Tang OS, Soohweer H, Seyberth HW, Lee SW, Ho PG. Pharmacokinetics of different routes of administration of misopristol. Hum Reprod 2002;17:332-6. (Pubitemid 34168436)
    • (2002) Human Reproduction , vol.17 , Issue.2 , pp. 332-336
    • Tang, O.S.1    Schweer, H.2    Seyberth, H.W.3    Lee, S.W.H.4    Ho, P.C.5
  • 8
    • 0036119768 scopus 로고    scopus 로고
    • Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: Efficacy and acceptability
    • Tang OS, Miao BY, Lee SW, Chung Ho. Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: Effi cacy and acceptability. Hum Reprod 2002;17:654-8. (Pubitemid 34232435)
    • (2002) Human Reproduction , vol.17 , Issue.3 , pp. 654-658
    • Tang, O.S.1    Miao, B.Y.2    Lee, S.W.H.3    Ho, P.C.4
  • 9
    • 0347946706 scopus 로고    scopus 로고
    • Effects of misoprostol on uterine contractility following different routes of administration
    • DOI 10.1093/humrep/deh005
    • Aronsson A, Bygdeman M, Gemzell-Danielsson K. Effects of misoprostol on uterine contractility following different routes of administration. Hum Reprod 2004;19:81-4. (Pubitemid 38072011)
    • (2004) Human Reproduction , vol.19 , Issue.1 , pp. 81-84
    • Aronsson, A.1    Bygdeman, M.2    Gemzell-Danielsson, K.3
  • 10
    • 33748360739 scopus 로고    scopus 로고
    • Misoprostol administered by epithelial routes: Drug absorption and uterine response
    • DOI 10.1097/01.AOG.0000230398.32794.9d, PII 0000625020060900000017
    • Meckstroth KR, Whitaker AK, Bertisch S, Goldberg AB, Danney PD. Misoprostol administered by epithelial routes: Drug absorption and uterine response. Obstet Gynecol 2006;108:582-90. (Pubitemid 44337099)
    • (2006) Obstetrics and Gynecology , vol.108 , Issue.3 , pp. 582-590
    • Meckstroth, K.R.1    Whitaker, A.K.2    Bertisch, S.3    Goldberg, A.B.4    Darney, P.D.5
  • 12
    • 0037248046 scopus 로고    scopus 로고
    • A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriages
    • DOI 10.1093/humrep/deg013
    • Tang OS, Lau WN, Ng EH, Lee SW, Ho PC. A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of fi rst trimester silent miscarriages. Hum Reprod 2003;18:176-81. (Pubitemid 36138873)
    • (2003) Human Reproduction , vol.18 , Issue.1 , pp. 176-181
    • Tang, O.S.1    Lau, W.N.T.2    Ng, E.H.Y.3    Lee, S.W.H.4    Ho, P.C.5
  • 14
    • 0347316383 scopus 로고    scopus 로고
    • Comparison between the sublingual and oral route of misoprostol for pre-abortion cervical priming in first trimester abortions
    • DOI 10.1093/humrep/deh001
    • Saxena P, Salhan S, Sarda N. Comparison between the sublingual and oral route of misoprostol for pre-abortion cervical priming in fi rst trimester abortions. Hum Reprod 2004;19:77-80. (Pubitemid 38072010)
    • (2004) Human Reproduction , vol.19 , Issue.1 , pp. 77-80
    • Saxena, P.1    Salhan, S.2    Sarda, N.3
  • 15
    • 36049003708 scopus 로고    scopus 로고
    • Misoprostol: Pharmacokinetic profiles effects on the uterus and side-effects
    • Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: Pharmacokinetic profi les, effects on the uterus and side-effects. Int J Gynecol Obstet 2007;99:160-7.
    • (2007) Int J Gynecol Obstet , vol.99 , pp. 160-167
    • Tang, O.S.1    Gemzell-Danielsson, K.2    Ho, P.C.3
  • 16
    • 0031728395 scopus 로고    scopus 로고
    • An effective regimen for early medical abortion: A report of 2000 consecutive cases
    • Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: A report of 2000 consecutive cases. Hum Reprod 1998;13:2962-5. (Pubitemid 28482759)
    • (1998) Human Reproduction , vol.13 , Issue.10 , pp. 2962-2965
    • Ashok, P.W.1    Penney, G.C.2    Flett, G.M.M.3    Templeton, A.4
  • 17
    • 0034107964 scopus 로고    scopus 로고
    • Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days
    • DOI 10.1016/S0010-7824(99)00119-5, PII S0010782499001195
    • Schaff EA, Fieldings SL, Eisinger SH, Stadalius LS, Fuller L. Low does Mifepristone followed by vaginal misoprostol at 48 hours for abortion upto 63 days. Contraceptions 2000;61:41-6. (Pubitemid 30169303)
    • (2000) Contraception , vol.61 , Issue.1 , pp. 41-46
    • Schaff, E.A.1    Fielding, S.L.2    Eisinger, S.H.3    Stadalius, L.S.4    Fuller, L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.